This HTML5 document contains 96 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
wdthttp://www.wikidata.org/prop/direct/
wdtnhttp://www.wikidata.org/prop/direct-normalized/
schemahttp://schema.org/
skoshttp://www.w3.org/2004/02/skos/core#
rdfshttp://www.w3.org/2000/01/rdf-schema#
wikibasehttp://wikiba.se/ontology#
phttp://www.wikidata.org/prop/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n11http://dx.doi.org/10.3275/
n4http://rdf.ncbi.nlm.nih.gov/pubchem/reference/
xsdhhttp://www.w3.org/2001/XMLSchema#
wdshttp://www.wikidata.org/entity/statement/
wdhttp://www.wikidata.org/entity/
n10https://scigraph.springernature.com/pub.10.3275/

Statements

Subject Item
wd:Q83974739
rdf:type
wikibase:Item
schema:description
scientific article published on 26 April 2011 im April 2011 veröffentlichter wissenschaftlicher Artikel artículu científicu espublizáu n'abril de 2011 wetenschappelijk artikel наукова стаття, опублікована у квітні 2011
p:P577
wds:Q83974739-7915CD6F-3EE4-47B6-A731-41D12D2AF9B2
wdt:P577
2011-04-26T00:00:00Z
p:P2888
wds:Q83974739-8EF2F499-0284-4117-867C-944DB6FDB5AC
wdt:P2888
n10:7684
p:P2860
wds:Q83974739-F95361E9-D2E1-44C5-9584-D13BB0C2A58A wds:Q83974739-F43A9C42-0D9E-42EB-9377-E99442948F89 wds:Q83974739-FE73E3B4-F039-4A48-81CB-21CBECF35409 wds:Q83974739-CAE9C144-A77D-4A39-8CDE-E7796F020BD7 wds:Q83974739-D07809D1-5358-4107-836E-DD8904E67950 wds:Q83974739-D9589749-2FE1-45D1-BD6C-09D1FA6461CE wds:Q83974739-D60A10E7-3BD4-4346-B6A2-9B023D349365 wds:Q83974739-E5E9548E-007F-4CF4-9B47-F158A7E17D0D wds:Q83974739-E28E03DC-74D4-40F8-9CE8-85CBCB6540C4 wds:Q83974739-978DB83A-9E0B-4D4E-8ABA-E485F221626B wds:Q83974739-A511E07E-3AA7-4C4E-A931-9EAB0B7B1A11 wds:Q83974739-A3CEC690-ADD7-44B0-AC78-14B1921F4D23 wds:Q83974739-A83C0912-58AD-4190-8ACA-708B16BAD2AA wds:Q83974739-A7093A69-37C6-428A-AB73-A272AE8E6E2B wds:Q83974739-865BAC90-5364-4EA2-B99F-9F0FEA89BFF2 wds:Q83974739-837A2F7D-0CFD-410D-A567-2509BD148B18 wds:Q83974739-86AC59C2-50B1-4B1D-852F-C295300CB26F wds:Q83974739-9613FBDB-E9F7-48D8-BCD0-42CF1105E696 wds:Q83974739-4C41DA8D-625A-4E0D-9B96-7272CCD82C1A wds:Q83974739-7429BF20-64BC-4592-8FB9-A6E47A2B88A1 wds:Q83974739-647281F2-8D6C-4A98-96D5-7A07F72B0B87 wds:Q83974739-7D46D8EA-9382-4317-921A-ED502648D07A wds:Q83974739-031B13A9-BF95-4531-BD7B-7746F5E8B9E0 wds:Q83974739-1A1A3992-EFB6-41B1-A029-AC3A04EA0817 wds:Q83974739-1A440536-2BAF-40E1-9050-CDC4567FC4F2
wdt:P2860
wd:Q36198443 wd:Q45267262 wd:Q36151136 wd:Q35578331 wd:Q35967340 wd:Q34720958 wd:Q36906236 wd:Q94707042 wd:Q37143496 wd:Q79734852 wd:Q43571615 wd:Q46389681 wd:Q22305467 wd:Q73668272 wd:Q37337512 wd:Q80471676 wd:Q46568302 wd:Q40568603 wd:Q81354466 wd:Q28238612 wd:Q73148413 wd:Q44514162 wd:Q34711990 wd:Q82003795 wd:Q34051003
p:P2093
wds:Q83974739-8A712365-6267-4B6D-ACA3-9F80892A0573 wds:Q83974739-38F74115-F2F0-490C-822A-9D8369F9DE28 wds:Q83974739-C29EDCE4-1941-4B65-9496-6E535F58ECFD wds:Q83974739-AF627C82-9B58-4661-B8D3-774B26FF58A9
wdt:P2093
J Mesa B Rodríguez C Zafon D Cabo
rdfs:label
Inability of recombinant human thyrotropin to predict the evolution from subclinical hypothyroidism to overt disease. A pilot study Inability of recombinant human thyrotropin to predict the evolution from subclinical hypothyroidism to overt disease. A pilot study
skos:prefLabel
Inability of recombinant human thyrotropin to predict the evolution from subclinical hypothyroidism to overt disease. A pilot study Inability of recombinant human thyrotropin to predict the evolution from subclinical hypothyroidism to overt disease. A pilot study
schema:name
Inability of recombinant human thyrotropin to predict the evolution from subclinical hypothyroidism to overt disease. A pilot study Inability of recombinant human thyrotropin to predict the evolution from subclinical hypothyroidism to overt disease. A pilot study
p:P50
wds:Q83974739-D449730C-CCE5-4BDD-A3CD-B70A98AAF4C9
wdt:P50
wd:Q68171156
p:P1476
wds:Q83974739-26B23468-09A1-46D6-8CB6-923818B37AC1
wdt:P1476
Inability of recombinant human thyrotropin to predict the evolution from subclinical hypothyroidism to overt disease. A pilot study
p:P304
wds:Q83974739-B2CC4D47-E1FE-4F3E-A729-67127A600677
wdt:P304
25-27
p:P31
wds:Q83974739-A2294365-110D-4037-B3EF-A41655CCE24E
wdt:P31
wd:Q13442814
p:P698
wds:Q83974739-21069083-F49B-4EB4-8552-6E98B8BD83CC
wdtn:P698
n4:21521938
wdt:P698
21521938
p:P1433
wds:Q83974739-03D80382-0B92-437F-BA67-DE1E6AB25AD8
wdt:P1433
wd:Q15766847
p:P433
wds:Q83974739-3F2D0CD6-AF30-468E-BE89-4B8D70DACDEB
p:P478
wds:Q83974739-17A85E8F-33E9-4246-B398-5C5F5EA87E13
wdt:P433
1
wdt:P478
35
p:P356
wds:Q83974739-8CF7B77B-7E11-47C0-B89B-94ED860A6F8E
wdtn:P356
n11:7684
wdt:P356
10.3275/7684
p:P6179
wds:Q83974739-876E728C-DAE5-45DE-9E8C-173FE5884B9A
wdt:P6179
1078388491